Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SMMT
SMMT logo

SMMT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SMMT News

Summit Therapeutics Shares Recover After CEO's $50M Stock Purchase

Jun 12 2026seekingalpha

Summit Therapeutics Withdraws $500M Public Offering Due to Market Conditions

Jun 11 2026seekingalpha

US Stocks Plunge Amid Rising Geopolitical Tensions

Jun 10 2026NASDAQ.COM

US Stocks Decline as Chip and Airline Stocks Weigh Down Market

Jun 10 2026NASDAQ.COM

US Stocks Decline as Inflation Data Eases Market Concerns

Jun 10 2026NASDAQ.COM

Summit Plans $500 Million Stock Offering to Fund Ivonescimab Development

Jun 10 2026stocktwits

Summit Therapeutics Launches $500M Underwritten Public Offering

Jun 09 2026seekingalpha

Summit Therapeutics Launches $500 Million Public Offering

Jun 09 2026Newsfilter

SMMT Events

06/14 14:00
BlackSky Short Interest Rises to 24.6%
Welcome to this week's installment of "The Short Interest Report" - The Fly's weekly recap of short interest trends among some of the most widely followed high-short-float stocks. Using the data from our partner, which utilizes the latest information from stock lenders to estimate short interest changes for thousands of publicly traded companies, this report will screen for some of biggest changes in short interest as a percentage of free float and days-to-cover ratios while also considering the short interest data on some of the more volatile and heavier-traded names of the week. Based on the availability of data from Ortex, the report tracks the trading period that covers prior Friday through Thursday of this week, excluding holidays. As a basis of comparison for stocks discussed below, the S&P 500 index was down 2.5%, the Nasdaq Composite was down 3.8%, the Russell 2000 index was down 0.5, the Russell 2000 Growth ETFwas down 1.3% and the Russell 2000 Value ETFwas flat in the five-day trading session range through June 11.SHORT INTEREST GAINERSOrtex-reported short interest in BlackSky Technologytroughed at a 9-month low of just below 20% on May 26 as the stock price was rounding out a nearly 3-times swing since the start of the year and a quadrupling since November lows. A timely downgrade from Jefferies suggesting that the excitement regarding space-themed stocks heading into the SpaceX IPO could be misplaced grounded the stock, however, and shares have since shed nearly 40% from their May 28 peak while also sparking renewed bearish interest. This week, short interest as a percentage of free float lifted from 21.9% to a three-month high of 24.6%, days-to-cover rose from 3.3 to 3.6 while the stock price fell 9.3%, with another 10% retreat on Friday. Year-to-date, BlackSky is still up a hefty 73%.Ortex-reported short interest in Summit Therapeuticstroughed just under 21% on May 18, rising gradually over the subsequent three weeks and then spiking sharply over the past few sessions. In the five-day period covered through Friday, Summit Therapeutics' short interest as a percentage of free float spiked from 22.7% to 28.0% - a three-week high. With a pick-up in trading volume over the past 10 trading days, days-to-cover on the name is up more incrementally, rising from 7.5 to 8.5 – a two-week high. The stock was off by 12% this week at a two-year-low, with the selloff gathering steam after the company's $500M equity offering. Shares also remain down 23% year-to-date.Ortex-reported short interest on Bobs Discount Furniturepeaked at a record-high of 28% on May 15, receded to 20% over the next two weeks, but has since bounced back toward those highs in June with rangebound price action in shares soothing any potential concerns of a violent short squeeze. This week, shorts as a percentage of free float rose from 23.7% to 27.5% and days-to-cover ticked up from 5.5 to 6.5. The stock was up about 2% in the five-day period covered but remains down 18% year to date. Assuming Friday's 3% gains hold, Bobs Discount is now down 19% from its IPO pricing level of $17.Ortex-reported short interest in Avis Budgettroughed at one-year lows around 35% on May 21 as bears took profits in conjunction with shares giving back the vast majority of their whopping 800% March-April gains. The stock appears to have found some footing, however, and while the advance from mid-May lows is far more gradual, shorts are accumulating into strength. This week, short interest as a percentage of free float rose from 39.6% to 45.8%, days-to-cover increased from 2.1 to 2.5%, and the stock advanced 9.7% in the five-day period through Thursday. Year-to-date, Avis Budget is now up 45%.SHORT INTEREST DECLINERSOrtex-reported short interest in HighPeak Energypeaked at a record high of 42.3% in the first week of June but fell sharply this week, sliding all the way down to a two-month low of 29%. Days-to-cover on the name also retreated by a meaningful margin, falling from 9.5 to 7.1 – a three-year low. A build-up in short exposure against the backdrop of higher energy prices boosting the sector may have finally culminated in a sharper short-squeeze outflow for the bears. While shares of HighPeak slipped about 3% in the five-day period through Thursday, the stock up 65% year-to-date and up 51% since the start of the Iran war.
06/11 10:00
Summit Therapeutics Withdraws Public Offering Plan
In a regulatory filing, Summit Therapeutics announced that effective June 10, 2026 it has withdrawn its previously announced proposed underwritten public offering of securities due to market conditions. As a result of such termination, no securities will be sold pursuant to the proposed underwritten public offering.

SMMT Monitor News

Summit Therapeutics Launches $500 Million Public Offering

Jun 12 2026

Summit Therapeutics Announces $500 Million Offering Amid Market Concerns

Jun 10 2026

Summit Therapeutics' Ivonescimab Shows Promising Results in Lung Cancer Trials

Jun 01 2026

H.C. Wainwright Downgrades Summit to Neutral Amid Trial Concerns

May 22 2026

Summit Therapeutics Reports Wider Q1 Loss Amid Clinical Progress

May 01 2026

Summit Therapeutics Inc. hits a 5-day low amid market decline

Apr 23 2026

Summit Therapeutics Inc. stock falls amid market gains

Apr 22 2026

Summit Therapeutics reaches 20-day high amid market gains

Apr 21 2026

SMMT Earnings Analysis

Summit Therapeutics: 2024 Earnings & Oncology Advances- Intellectia AI™
1 years ago

People Also Watch